ClinicalTrials.gov
public full text
Public Domain
Atrasentan in Patients With Proteinuric Glomerular Diseases
The AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease who are at risk of progressive loss of renal function.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure#915850
- Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan#1138158
- Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects#872048
- Incidencia de la Anemia Ferropriva asociado al parto prematuro en gestantes. Hospital general Dr. Liborio Panchana Sotomayor 2019.#953341
- Development of Predictive Biomarkers#850563
Record · ID 847953
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive